{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:46:00Z","timestamp":1761662760541},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,6,18]],"date-time":"2009-06-18T00:00:00Z","timestamp":1245283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2009,6,18]],"date-time":"2009-06-18T00:00:00Z","timestamp":1245283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Chemokines and their receptors control immune cell migration during infections as well as in autoimmune responses. A 32 bp deletion in the gene of the chemokine receptor CCR5 confers protection against HIV infection, but has also been reported to decrease susceptibility to rheumatoid arthritis (RA). The influence of this deletion variant on the clinical course of this autoimmune disease was investigated.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Genotyping for CCR5d32 was performed by PCR and subsequent electrophoretic fragment length determination. For the clinical analysis, the following extra-articular manifestations of RA were documented by the rheumatologist following the patient: presence of rheumatoid nodules, major organ vasculitis, pulmonary fibrosis, serositis or a Raynaud's syndrome. All documented CRP levels were analyzed retrospectively, and the last available hand and feet radiographs were analyzed with regards to the presence or absence of erosive disease.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Analysis of the CCR5 polymorphism in 503 RA patients and in 459 age-matched healthy controls revealed a significantly decreased disease susceptibility for carriers of the CCR5d32 deletion (Odds ratio 0.67, <jats:italic>P<\/jats:italic> = 0.0437). Within the RA patient cohort, CCR5d32 was significantly less frequent in patients with extra-articular manifestations compared with those with limited, articular disease (13.2% versus 22.8%, <jats:italic>P<\/jats:italic> = 0.0374). In addition, the deletion was associated with significantly lower average CRP levels over time (median 8.85 vs. median 14.1, <jats:italic>P<\/jats:italic> = 0.0041) and had a protective effect against the development of erosive disease (OR = 0.40, <jats:italic>P<\/jats:italic> = 0.0047). Intriguingly, homozygosity for the RA associated DNASE2 -1066 G allele had an additive effect on the disease susceptibility conferred by the wt allele of CCR5 (OR = 2.24, <jats:italic>P<\/jats:italic> = 0.0051 for carrier of both RA associated alleles)<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>The presence of CCR5d32 significantly influenced disease susceptibility to and clinical course of RA in a German study population. The protective effect of this deletion, which has been described to lead to a decreased receptor expression in heterozygous patients, underlines the importance of chemokines in the pathogenesis of RA.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar2733","type":"journal-article","created":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T18:14:02Z","timestamp":1247076842000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritis"],"prefix":"10.1186","volume":"11","author":[{"given":"Manuela","family":"Rossol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Pierer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sybille","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Key\u00dfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Burkhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Baerwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,18]]},"reference":[{"key":"2573_CR1","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N","volume":"44","author":"KJ Katschke Jr","year":"2001","unstructured":"Katschke KJ, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, Ponath P, Park CC, Pope RM, Koch AE: Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes\/macrophages in rheumatoid arthritis. Arthritis Rheum. 2001, 44: 1022-1032. 10.1002\/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N.","journal-title":"Arthritis Rheum"},{"key":"2573_CR2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/1529-0131(199905)42:5<981::AID-ANR17>3.0.CO;2-4","volume":"42","author":"M Mack","year":"1999","unstructured":"Mack M, Bruhl H, Gruber R, Jaeger C, Cihak J, Eiter V, Plachy J, Stangassinger M, Uhlig K, Schattenkirchner M, Schlondorff D: Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum. 1999, 42: 981-988. 10.1002\/1529-0131(199905)42:5<981::AID-ANR17>3.0.CO;2-4.","journal-title":"Arthritis Rheum"},{"key":"2573_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/382722a0","volume":"382","author":"M Samson","year":"1996","unstructured":"Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996, 382: 722-725. 10.1038\/382722a0.","journal-title":"Nature"},{"key":"2573_CR4","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1126\/science.273.5283.1856","volume":"273","author":"M Dean","year":"1996","unstructured":"Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 1996, 273: 1856-1862. 10.1126\/science.273.5283.1856.","journal-title":"Science"},{"key":"2573_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/1529-0131(199905)42:5<989::AID-ANR18>3.0.CO;2-U","volume":"42","author":"JJ Gomez-Reino","year":"1999","unstructured":"Gomez-Reino JJ, Pablos JL, Carreira PE, Santiago B, Serrano L, Vicario JL, Balsa A, Figueroa M, de Juan MD: Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum. 1999, 42: 989-992. 10.1002\/1529-0131(199905)42:5<989::AID-ANR18>3.0.CO;2-U.","journal-title":"Arthritis Rheum"},{"key":"2573_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/ard.2004.023333","volume":"64","author":"V Pokorny","year":"2005","unstructured":"Pokorny V, McQueen F, Yeoman S, Merriman M, Merriman A, Harrison A, Highton J, McLean L: Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis. Ann Rheum Dis. 2005, 64: 487-490. 10.1136\/ard.2004.023333.","journal-title":"Ann Rheum Dis"},{"key":"2573_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/sj.gene.6364298","volume":"7","author":"S Prahalad","year":"2006","unstructured":"Prahalad S: Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis. Genes Immun. 2006, 7: 264-268. 10.1038\/sj.gene.6364298.","journal-title":"Genes Immun"},{"key":"2573_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2350-8-33","volume":"8","author":"E Lindner","year":"2007","unstructured":"Lindner E, Nordang GB, Melum E, Flato B, Selvaag AM, Thorsby E, Kvien TK, Forre OT, Lie BA: Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis. BMC Med Genet. 2007, 8: 33-10.1186\/1471-2350-8-33.","journal-title":"BMC Med Genet"},{"key":"2573_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/ard.2007.075028","volume":"67","author":"C McKinney","year":"2008","unstructured":"McKinney C, Merriman ME, Chapman PT, Gow PJ, Harrison AA, Highton J, Jones PB, McLean L, O'Donnell JL, Pokorny V, Spellerberg M, Stamp LK, Willis J, Steer S, Merriman TR: Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis. 2008, 67: 409-413. 10.1136\/ard.2007.075028.","journal-title":"Ann Rheum Dis"},{"key":"2573_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jneuroim.2005.07.025","volume":"169","author":"OH Kantarci","year":"2005","unstructured":"Kantarci OH, Morales Y, Ziemer PA, Hebrink DD, Mahad DJ, Atkinson EJ, Achenbach SJ, De Andrade M, Mack M, Ransohoff RM, Lassmann H, Bruck W, Weinshenker BG, Lucchinetti CF: CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis. J Neuroimmunol. 2005, 169: 137-143. 10.1016\/j.jneuroim.2005.07.025.","journal-title":"J Neuroimmunol"},{"key":"2573_CR11","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/ard.2007.078048","volume":"67","author":"M Mamtani","year":"2008","unstructured":"Mamtani M, Rovin B, Brey R, Camargo JF, Kulkarni H, Herrera M, Correa P, Holliday S, Anaya JM, Ahuja SK: CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis. 2008, 67: 1076-1083. 10.1136\/ard.2007.078048.","journal-title":"Ann Rheum Dis"},{"key":"2573_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0165-2478(01)00199-7","volume":"77","author":"H Herfarth","year":"2001","unstructured":"Herfarth H, Pollok-Kopp B, Goke M, Press A, Oppermann M: Polymorphism of CC chemokine receptors CCR2 and CCR5 in Crohn's disease. Immunol Lett. 2001, 77: 113-117. 10.1016\/S0165-2478(01)00199-7.","journal-title":"Immunol Lett"},{"key":"2573_CR13","first-page":"701","volume":"20","author":"M Petrek","year":"2002","unstructured":"Petrek M, Cermakova Z, Hutyrova B, Micekova D, Drabek J, Rovensky J, Bosak V: CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjogren's syndrome. Clin Exp Rheumatol. 2002, 20: 701-703.","journal-title":"Clin Exp Rheumatol"},{"key":"2573_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2370.2004.00444.x","volume":"31","author":"X Yang","year":"2004","unstructured":"Yang X, Ahmad T, Gogus F, Verity D, Wallace GR, Madanat W, Kanawati CA, Stanford MR, Fortune F, Jewell DP, Marshall SE: Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behcet's disease. Eur J Immunogenet. 2004, 31: 11-14. 10.1111\/j.1365-2370.2004.00444.x.","journal-title":"Eur J Immunogenet"},{"key":"2573_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1164\/rccm.200412-1707OC","volume":"172","author":"P Spagnolo","year":"2005","unstructured":"Spagnolo P, Renzoni EA, Wells AU, Copley SJ, Desai SR, Sato H, Grutters JC, Abdallah A, Taegtmeyer A, du Bois RM, Welsh KI: C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. Am J Respir Crit Care Med. 2005, 172: 721-728. 10.1164\/rccm.200412-1707OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2573_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/01.MIB.0000209790.21737.28","volume":"12","author":"L Henckaerts","year":"2006","unstructured":"Henckaerts L, Fevery J, Van Steenbergen W, Verslype C, Yap P, Nevens F, Roskams T, Libbrecht L, Rutgeerts P, Vermeire S: CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis. Inflamm Bowel Dis. 2006, 12: 272-277. 10.1097\/01.MIB.0000209790.21737.28.","journal-title":"Inflamm Bowel Dis"},{"key":"2573_CR17","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1161\/STROKEAHA.107.504381","volume":"39","author":"AR Afzal","year":"2008","unstructured":"Afzal AR, Kiechl S, Daryani YP, Weerasinghe A, Zhang Y, Reindl M, Mayr A, Weger S, Xu Q, Willeit J: Common CCR5-del32 frameshift mutation associated with serum levels of inflammatory markers and cardiovascular disease risk in the Bruneck population. Stroke. 2008, 39: 1972-1978. 10.1161\/STROKEAHA.107.504381.","journal-title":"Stroke"},{"key":"2573_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/sj.gene.6364317","volume":"7","author":"S Prahalad","year":"2006","unstructured":"Prahalad S, Bohnsack JF, Jorde LB, Whiting A, Clifford B, Dunn D, Weiss R, Moroldo M, Thompson SD, Glass DN, Bamshad MJ: Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis. Genes Immun. 2006, 7: 468-475. 10.1038\/sj.gene.6364317.","journal-title":"Genes Immun"},{"key":"2573_CR19","first-page":"1462","volume":"25","author":"P Garred","year":"1998","unstructured":"Garred P, Madsen HO, Petersen J, Marquart H, Hansen TM, Freiesleben Sorensen S, Volck B, Svejgaard A, Andersen V: CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol. 1998, 25: 1462-1465.","journal-title":"J Rheumatol"},{"key":"2573_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/sj.gene.6363673","volume":"1","author":"I Zapico","year":"2000","unstructured":"Zapico I, Coto E, Rodriguez A, Alvarez C, Torre JC, Alvarez V: CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun. 2000, 1: 288-289. 10.1038\/sj.gene.6363673.","journal-title":"Genes Immun"},{"key":"2573_CR21","volume-title":"Ann Rheum Dis","author":"M Rossol","year":"2008","unstructured":"Rossol M, Pierer M, Arnold S, Keyszer G, Burkhardt H, Baerwald C, Wagner U: Homozygosity for DNASE2 single-nucleotide polymorphisms in the 5' regulatory region is associated with rheumatoid arthritis. Ann Rheum Dis. 2008"},{"key":"2573_CR22","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1186\/ar1945","volume":"8","author":"M Pierer","year":"2006","unstructured":"Pierer M, Kaltenhauser S, Arnold S, Wahle M, Baerwald C, Hantzschel H, Wagner U: Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: higher frequency of the risk allele in male compared to female patients. Arthritis Res Ther. 2006, 8: R75-10.1186\/ar1945.","journal-title":"Arthritis Res Ther"},{"key":"2573_CR23","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1136\/ard.2007.083782","volume":"67","author":"O Malysheva","year":"2008","unstructured":"Malysheva O, Pierer M, Wagner U, Wahle M, Baerwald CG: Association between beta2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope. Ann Rheum Dis. 2008, 67: 1759-1764. 10.1136\/ard.2007.083782.","journal-title":"Ann Rheum Dis"},{"key":"2573_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/immu.200390010","volume":"33","author":"U Wagner","year":"2003","unstructured":"Wagner U, Pierer M, Kaltenhauser S, Wilke B, Seidel W, Arnold S, Hantzschel H: Clonally expanded CD4+CD28null T cells in rheumatoid arthritis use distinct combinations of T cell receptor BV and BJ elements. Eur J Immunol. 2003, 33: 79-84. 10.1002\/immu.200390010.","journal-title":"Eur J Immunol"},{"key":"2573_CR25","doi-asserted-by":"publisher","first-page":"R199","DOI":"10.1186\/ar1164","volume":"6","author":"S Dorr","year":"2004","unstructured":"Dorr S, Lechtenbohmer N, Rau R, Herborn G, Wagner U, Muller-Myhsok B, Hansmann I, Keyszer G: Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res Ther. 2004, 6: R199-207. 10.1186\/ar1164.","journal-title":"Arthritis Res Ther"},{"key":"2573_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/art.21498","volume":"54","author":"H Burkhardt","year":"2006","unstructured":"Burkhardt H, Huffmeier U, Spriewald B, Bohm B, Rau R, Kallert S, Engstrom A, Holmdahl R, Reis A: Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis. Arthritis Rheum. 2006, 54: 82-89. 10.1002\/art.21498.","journal-title":"Arthritis Rheum"},{"key":"2573_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/ard.2007.073239","volume":"67","author":"U Huffmeier","year":"2008","unstructured":"Huffmeier U, Boiers U, Lascorz J, Reis A, Burkhardt H: Loss-of-function mutations in the filaggrin gene: no contribution to disease susceptibility, but to autoantibody formation against citrullinated peptides in early rheumatoid arthritis. Ann Rheum Dis. 2008, 67: 131-133. 10.1136\/ard.2007.073239.","journal-title":"Ann Rheum Dis"},{"key":"2573_CR28","first-page":"2094","volume":"25","author":"R Rau","year":"1998","unstructured":"Rau R, Wassenberg S, Herborn G, Stucki G, Gebler A: A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol. 1998, 25: 2094-2107.","journal-title":"J Rheumatol"},{"key":"2573_CR29","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1371\/journal.pbio.0030339","volume":"3","author":"J Novembre","year":"2005","unstructured":"Novembre J, Galvani AP, Slatkin M: The geographic spread of the CCR5 Delta32 HIV-resistance allele. PLoS Biol. 2005, 3: e339-10.1371\/journal.pbio.0030339.","journal-title":"PLoS Biol"},{"key":"2573_CR30","first-page":"351","volume":"21","author":"JA Zuniga","year":"2003","unstructured":"Zuniga JA, Villarreal-Garza C, Flores E, Barquera R, Perez-Hernandez N, Montes de Oca JV, Cardiel MH, Vargas-Alarcon G, Granados J: Biological relevance of the polymorphism in the CCR5 gene in refractory and non-refractory rheumatoid arthritis in Mexicans. Clin Exp Rheumatol. 2003, 21: 351-354.","journal-title":"Clin Exp Rheumatol"},{"key":"2573_CR31","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nature05245","volume":"443","author":"K Kawane","year":"2006","unstructured":"Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, Yoshioka Y, Yoshikawa H, Nagata S: Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature. 2006, 443: 998-1002. 10.1038\/nature05245.","journal-title":"Nature"},{"key":"2573_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/art.20850","volume":"52","author":"MP Vierboom","year":"2005","unstructured":"Vierboom MP, Zavodny PJ, Chou CC, Tagat JR, Pugliese-Sivo C, Strizki J, Steensma RW, McCombie SW, Celebi-Paul L, Remarque E, Jonker M, Narula SK, Hart B: Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5. Arthritis Rheum. 2005, 52: 627-636. 10.1002\/art.20850.","journal-title":"Arthritis Rheum"},{"key":"2573_CR33","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1084\/jem.185.9.1681","volume":"185","author":"L Wu","year":"1997","unstructured":"Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, Mackay CR: CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med. 1997, 185: 1681-1691. 10.1084\/jem.185.9.1681.","journal-title":"J Exp Med"},{"key":"2573_CR34","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/ard.2003.008599","volume":"63","author":"R Nissinen","year":"2004","unstructured":"Nissinen R, Leirisalo-Repo M, Peltomaa R, Palosuo T, Vaarala O: Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis. Ann Rheum Dis. 2004, 63: 681-687. 10.1136\/ard.2003.008599.","journal-title":"Ann Rheum Dis"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2733.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar2733\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2733.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:15:58Z","timestamp":1728386158000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar2733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,18]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,6]]}},"alternative-id":["2573"],"URL":"https:\/\/doi.org\/10.1186\/ar2733","relation":{},"ISSN":["1478-6354"],"issn-type":[{"type":"electronic","value":"1478-6354"}],"subject":[],"published":{"date-parts":[[2009,6,18]]},"assertion":[{"value":"5 December 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R91"}}